Recalls & Warnings November 24, 2018 Dangerous Drug In Supplements for Pain and Anxiety On November 20, 2018, the FDA announced it has issued warning letters to two companies for the illegal marketing of products labeled as dietary supplements that contain the opioid-like drug tianeptine
However, novel advances have led to more stable and orally bioavailable preparations that may augment this peptides already considerable therapeutic potential, especially as it affects the GI tract
For example, some peptides are praised for their healing properties and pain relief, while others are used for weight loss, improving sleep, hair growth, immune function, sexual health, and muscle-building
It is intended solely for qualified professionals in controlled lab settings